DTIC-Dome

DTIC-Dome is a brand name of dacarbazine, approved by the FDA in the following formulation(s):

DTIC-DOME (dacarbazine - injectable; injection)

• 
  Manufacturer: BAYER HLTHCARE
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 100MG/VIAL ^[RLD][AP], 200MG/VIAL ^[RLD][AP]

Has a generic version of DTIC-Dome been approved?

Yes. The following products are equivalent to DTIC-Dome:

dacarbazine injectable; injection

• 
  Manufacturer: APP PHARMS
  
  Approval date: August 27, 1999
  
  Strength(s): 100MG/VIAL ^[AP], 200MG/VIAL ^[AP]


• 
  Manufacturer: BEDFORD
  
  Approval date: June 15, 2001
  
  Strength(s): 200MG/VIAL ^[AP]


• 
  Manufacturer: HOSPIRA
  
  Approval date: October 18, 2001
  
  Strength(s): 200MG/VIAL ^[AP]


• 
  Manufacturer: TEVA PARENTERAL
  
  Approval date: August 27, 1998
  
  Strength(s): 200MG/VIAL ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of DTIC-Dome. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with DTIC-Dome.

See also...

• DTIC-Dome Consumer Information (Wolters Kluwer)
• Dtic-Dome Consumer Information (Cerner Multum)
• Dtic-Dome Advanced Consumer Information (Micromedex)
• DTIC-Dome AHFS DI Monographs (ASHP)
• Dacarbazine Consumer Information (Wolters Kluwer)
• Dacarbazine Consumer Information (Cerner Multum)
• Dacarbazine Intravenous, Injection Advanced Consumer Information (Micromedex)
• Dacarbazine AHFS DI Monographs (ASHP)